| 000 | 01704 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517062202.0 | ||
| 264 | 0 | _c20160623 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1365-2249 | ||
| 024 | 7 |
_a10.1111/cei.12739 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVierboom, M P M | |
| 245 | 0 | 0 |
_aClinical efficacy of a new CD28-targeting antagonist of T cell co-stimulation in a non-human primate model of collagen-induced arthritis. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMar 2016 |
||
| 300 |
_a405-18 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAbatacept _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArthritis, Experimental |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aCD28 Antigens _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCollagen _ximmunology |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMacaca mulatta |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBreedveld, E | |
| 700 | 1 | _aKap, Y S | |
| 700 | 1 | _aMary, C | |
| 700 | 1 | _aPoirier, N | |
| 700 | 1 | _a't Hart, B A | |
| 700 | 1 | _aVanhove, B | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 183 _gno. 3 _gp. 405-18 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cei.12739 _zAvailable from publisher's website |
| 999 |
_c25422329 _d25422329 |
||